Search Results 7721-7730 of 40183 for oral
No medical condition that could interfere with oral medication intake (e.g., frequent vomiting or partial bowel obstruction); No other prior malignancies ...
... oral drug intake; No other malignancy within the past 5 years except nonmelanoma skin cancer, carcinoma in situ of the cervix, or ductal carcinoma in situ of ...
Niraparib is an oral poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) 1/2 inhibitor that has shown clinical activity in patients with ovarian cancer.
Topical skin steroid treatment, non-absorbable oral steroid treatment for GI GVHD, and resumption of GVHD prophylaxis agents (e.g., calcineurin inhibitors) are ...
Mayo Clinic Q&A: Understanding surgical options for oral cancer featured image. Cancer. Mayo Clinic Q&A: Understanding surgical options for oral cancer.
Mayo Clinic Q&A: Understanding surgical options for oral cancer featured image. Cancer. Mayo Clinic Q&A: Understanding surgical options for oral cancer. Mayo ...
... oral, injected, or implanted hormonal methods, an intrauterine device, (IUD), or intrauterine system for the entire duration of the treatment period and for ...
Prehospitalization narcotic use if weekly average daily oral morphine equivalent of > 20 mg. Chronic pain syndromes such as fibromyalgia. Extensive surgery ...
Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!